These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11941962)

  • 1. Circulating soluble-CD30 (sCD30) in patients with HCV-related chronic hepatitis and in patients with alcoholic liver disease.
    De Lazzari F; Ravagnan P; Tenderini M; Vicarioto MA; Galliani EA; Lorenzoni U; Popovic A; Floreani A
    Hepatogastroenterology; 2002; 49(43):231-4. PubMed ID: 11941962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of soluble CD26 and CD30 levels correlate with response to interferon plus ribavirin therapy in patients with chronic hepatitis C.
    Yang SS; Fu LS; Chang CS; Yeh HZ; Chen GH; Kao JH
    J Gastroenterol Hepatol; 2006 Dec; 21(12):1789-93. PubMed ID: 17074015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble CD30 serum levels before and after treatment with alpha-interferon in patients with chronic hepatitis C.
    Di Cesare E; Spadaro A; Ajello A; Ferraù O; Alessi N; Luigiano C; Melluso R; Freni MA
    Clin Chem Lab Med; 2005; 43(8):823-6. PubMed ID: 16201891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD26/30 levels before and after treatment with interferon-alpha and ribavirin combination therapy in a pediatric hepatitis C patient.
    Liao YR; Yen CP; Lin CC; Fu LS; Chiu CC; Chi CS
    J Microbiol Immunol Infect; 2004 Feb; 37(1):67-70. PubMed ID: 15060691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total serum IgE levels in chronic hepatitis C: influence of interferon alpha therapy.
    González-Quintela A; Alende MR; Lojo S; Pérez LF; Padín E; Tomé S; Vidal C
    Int Arch Allergy Immunol; 2001 Jun; 125(2):176-81. PubMed ID: 11435735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum immunoglobulins (IgG, IgA, IgM) in chronic hepatitis C. A comparison with non-cirrhotic alcoholic liver disease.
    Gonzàlez-Quintela A; Alende MR; Gamallo R; Gonzàlez-Gil P; López-Ben S; Tomé S; Otero E; Torre JA
    Hepatogastroenterology; 2003; 50(54):2121-6. PubMed ID: 14696478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble CD30 serum levels in atopic dermatitis and bronchial asthma and its relationship with disease severity in pediatric age.
    Heshmat NM; El-Hadidi ES
    Pediatr Allergy Immunol; 2006 Jun; 17(4):297-303. PubMed ID: 16771784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD30 and cyclosporine in severe atopic dermatitis.
    Caproni M; Salvatore E; Cardinali C; Brazzini B; Fabbri P
    Int Arch Allergy Immunol; 2000 Apr; 121(4):324-8. PubMed ID: 10828723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
    Alvarado Esquivel C; Elewaut A; Philippé J; Elewaut AE; Desombere I; Maertens G; Leroux-Roels G
    Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of soluble CD30 in chronic hepatitis B virus infection.
    Fattovich G; Vinante F; Giustina G; Morosato L; Alberti A; Ruol A; Pizzolo G
    Clin Exp Immunol; 1996 Jan; 103(1):105-10. PubMed ID: 8565268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fluticasone propionate on soluble CD30 release in patients with severe allergic asthma.
    Purello-D'Ambrosio F; Gangemi S; Ruello G; Marotta G; Merendino RA
    J Investig Allergol Clin Immunol; 2000; 10(5):283-5. PubMed ID: 11108439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of soluble CD30 in patients with atopic dermatitis: correlations with age, disease duration and severity.
    El Mongy S; Metwaly SS; Arafat MS; Hady HA
    Egypt J Immunol; 2008; 15(1):123-9. PubMed ID: 20306677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helper T cell cytokine response to ribavirin priming before combined treatment with interferon alpha and ribavirin for patients with chronic hepatitis C.
    Furusyo N; Kubo N; Toyoda K; Takeoka H; Nabeshima S; Murata M; Nakamuta M; Hayashi J
    Antiviral Res; 2005 Jul; 67(1):46-54. PubMed ID: 15913800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated soluble CD30 characterizes patients with hepatitis C virus-induced liver allograft cirrhosis.
    Bharat A; Narayanan K; Golocheikine A; Steward N; Crippin J; Lisker-Melman M; Shenoy S; Lowell J; Chapman WC; Mohanakumar T
    Transplantation; 2007 Dec; 84(12):1704-7. PubMed ID: 18165785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating levels of soluble CD30, a marker of cells producing Th2-type cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity.
    Caligaris-Cappio F; Bertero MT; Converso M; Stacchini A; Vinante F; Romagnani S; Pizzolo G
    Clin Exp Rheumatol; 1995; 13(3):339-43. PubMed ID: 7554561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum soluble CD30 levels in Behçet's disease.
    Düzgün N; Ayaslioglu E; Tutkak H
    Clin Exp Rheumatol; 2004; 22(4 Suppl 34):S17-20. PubMed ID: 15515777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum levels of soluble CD30 molecule in hepatitis B virus infection].
    Monsalve F; Romero-A T; Estévez J; Costa L; Callejas D
    Rev Med Chil; 2001 Nov; 129(11):1248-52. PubMed ID: 11836876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do the initial serum level changes of sCD26 have ability to predict successful treatment with IFN-α among naïve chronic hepatitis B patients?
    Alavi-Moghaddam M; Alavian SM; Aalaei-Andabili SH; Eslami-Far A
    Vaccine; 2011 Nov; 29(48):9093-7. PubMed ID: 21893143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous CD30+ cells in children with atopic dermatitis.
    Cavagni G; Caffarelli C; Facchetti F; Brugnoni D; Notarangelo LD; Tosoni C; Altobelli R
    Int Arch Allergy Immunol; 2000 Mar; 121(3):224-8. PubMed ID: 10729781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of pre- and posttransplantation serum interferon-gamma and soluble CD30 for predicting liver allograft rejection.
    Kim KH; Oh EJ; Jung ES; Park YJ; Choi JY; Kim DG; Lee KY; Kang CS
    Transplant Proc; 2006 Jun; 38(5):1429-31. PubMed ID: 16797323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.